Articles
SULT1A1 + Minoxidil Human Study Published (Update 6/18/21) As foretold by Dr. Andy Goren below, Applied Biology has published a peer-reviewed study comparing the effect of the SULT1A1 booster in conjunction with minoxidil to minoxidil alone. The study titled “SULT1A1 (Minoxidil Sulfotransferase) Enzyme Booster Significantly Improves Response to Topical Minoxidil for Hair Regrowth” was published online…
Read More
Could AI, the hottest topic in science and technology, bring about the new and successful hair growth treatments we have been waiting for? We may find out sooner than you think. Last month, while reading an interesting article on the evolution of drug discovery, I was pleasantly surprised to learn about new research being done…
Read More
In this article I have a brief update to share regarding the anticipated release of a product based on the WAY-316606 research by Giuliani Pharma. After a long break in communication I’ve received some updated information regarding the development of a WAY-316606 analog product from Dr. Barbara Marzani, Project Manager of Research & Development at…
Read More
Hair Growth Compounds In Development – Update (8/30/20) As mentioned in the original article, Dr. Tsuji also made an online presentation for the Adva Corporation on August 25, 2020. I attempted to attend the lecture but it seemed that residents outside of Japan were not permitted to join the Zoom conference. Luckily, our jovial Youtuber…
Read More
Stemore of Korea has recently updated their website with exciting new information. Asia’s #1 Hair Loss Cure Research Company I remember reading that Stemore hoped to one day become Asia’s leading company in the field of hair loss cure research and development. I think after reading this article you may agree that they have already…
Read More
Koehler Lab Identifies Partner To Move Technology Forward: Update (7/7/21) About one year after this article was originally published, I have received a noteworthy update to share from Dr. Karl Koehler. Most importantly, as you read in the heading, an undisclosed company has stepped up to the plate to further Koehler’s research towards the clinic.…
Read More
We have yet another company moving towards a pivotal trial for hair regrowth in 2020. On June 4, 2020, Follica issued a press release to announce a positive ‘end of phase 2 meeting’ with the US FDA in preparation to begin a phase 3 trial this year. The release also outlines details of Follica’s phase…
Read More
US Male Phase 2 Pyrilutamide Trial Underway: Update (3/1/22) Consistent progress is the M.O. of Kintor Pharma. On March 1, 2022 it was announced that the first patients in a US phase 2 trial for males have received dosing. The four cohorts in the trial will receive topical dosing of either 2.5 mg pyrilutamide twice…
Read More
Update (6/22/20) The Manager of Recruitment at the California Dermatology & Clinical Research Institute reached out to me over the weekend to let me know that their site is still seeking participants for the HST-001 trial. Recruitment for the trial is scheduled to close in about 3 weeks so if you live in the San…
Read More
Today, HairClone sent out its latest newsletter and first official update of 2020. Newsletter May 2020 Here are the important bullet points from HairClone’s latest newsletter including an invitation to complete a survey for the company: Business News In Oct 2019, we were successful in winning a significant 15 month grant from the UK Government…
Read More